SHARE: +/-: -0.85 SEK / Bid: 10.15 SEK / Ask: 10.70 SEK / Price: 10.15 SEK / High: 11.00 SEK / Low: 10.00 SEK / Quantity: 13 804 / Turnover: 143 190 SEK / 2019-10-17 13:02 (CEST)
 

News

Spago Imaging enters a new phase

Spago Imaging enters a new phase which requires reinforced competences within pre-clinical and early clinical development. Spago has therefore chosen to engage Truly Translational AB as partner. http://www.trulytranslational.com/    
Read more

Spago Imaging AB presents data on new MR contrast agent Spago Pix at ECR in Vienna.

Spago Imaging visited the radiology meeting ECR in Vienna to present data on the Spago Pix, a nanosized polymeric manganese-containing contrast agent. As shown by MR-analysis as well as chemical analysis and immunohistochemistry in a clinically relevant mouse model of breast cancer, Spago Pix selectively leaks into tumor tissue where…
Read more

Spago verifies nanoparticle properties at Maxlab.

Spago has verified size, composition, and manganese coordination geometry for the Spagopix MRI contrast agent. The results were generated in collaboration with the scientists at Maxlab in Lund, Sweden. The techniques used were XAFS and SAXS, both utilizing the high intensity, monochromatic X-rays generated by the Maxlab accelerator. Size and…
Read more

Information on initial cost of SPAGO shares for shareholders of Accelerator

As previously announced, Accelerator distributed its holdings in SPAGO Imaging to the shareholders of Accelerator Nordic. The Swedish tax authorities have announced information on how to determine the price for such shares, please see below (in Swedish).   Accelerator Nordics utdelning av innehav i SPAGO Imaging Årsstämman i Accelerator den…
Read more

Breast MRI helps assess patient prognosis and change treatment plan

Aunt Minnie reports from American Society of Breast Surgeons (ASBS) annual meeting in Chicago that a study group from Michigan lead by Dr. Sukamal Saha reached the conclusion that breast MRI helps assess patient prognosis:   In breast cancer patients diagnosed through routine screening mammography, those with additional invasive lesions identified…
Read more

SPAGO Pix Properties Verified at MAX-Lab

SPAGO Imaging received a Science Link grant to use the state-of-the-art synchrotron at MAX-Lab, Lund, for advanced structure analysis of the nanomaterial in SPAGO’s MRI contrast agent, SPAGO Pix. The analyses performed with the XANES (X-ray Absorption Near Edge Structure) technique verified essential information about the material. For further information…
Read more

The SPAGO BTAs are traded on AktieTorget

Starting 27 December, SPAGO Imaging's BTAs are being traded on AktieTorget under SPAG BTA (SE0004950608).
Read more

SPAGO's issue of shares fully subscribed

The new share issue of a maximum 1 479 543 shares was fully subscribed during the subscription period 20 November to 5 December 2012. Accelerator's shareholders have subscribed to 82 percent of the new shares. This share issue will provide SPAGO Imaging with SEK 20 994 715 before issue costs. For…
Read more

Veckans Affärer: " Håll koll på spännande avknoppning"

The Swedish business magazine Veckans Affärer comments the exiting spinoff of SPAGO Imaging from Accelerator. Read the article here (in Swedish).
Read more

SPAGO Imaging Announces Memorandum for New Shares Issue

SPAGO Imaging offentliggör memorandum avseende riktad nyemission Styrelsen för SPAGO Imaging AB (publ) ("SPAGO"), dotterbolag till Accelerator Nordic AB (publ) ("Accelerator"), har upprättat ett memorandum avseende riktad nyemission med förtur för aktieägare i Accelerator samt särskilt inbjudna externa investerare. Memorandumet finns tillgängligt på http://www.spagoimaging.se och http://www.acceleratorab.se. Memorandumet kan även erhållas…
Read more